These are the five stocks to watch heading into Wednesday, November 18, 2026. Each received a bullish rating change or new coverage that circulated on Tuesday, November 17. Stocks fell sharply on Monday, November 16, as Nvidia led another technology sell-off. The S&P 500 dropped 145.08 points, or 1.9%, to 7,416.59. The Dow Jones Industrial Average fell 739.38 points, or 1.4%, to 51,608.17, and the Nasdaq Composite lost 626.52 points, or 2.5%, to 24,509.76. Declines were more modest early on November 17, with the S&P 500 down 0.2% around 9:40 a.m. ET. Nvidia was scheduled to report after the close on November 17, Target and Lowe's report on November 18, Walmart reports on November 19, and Anthropic's initial public offering is expected on November 19.
The five ideas below span networking hardware, medical devices, asset management, discount retail, and online auto retail. Editorial notes only, not investment advice.
Cisco Systems (CSCO) β HSBC and DZ Bank Upgrade the Networking Leader
HSBC analyst Abhishek Shukla upgraded Cisco to Buy from Hold and raised his target to $133.00 from $120.00, and DZ Bank also moved to Buy with a $125.00 target. Shukla noted the stock trades at 16.1 times estimated 2027 non-GAAP earnings against a sector median of 20.3 times. He added that Cisco said hyperscaler AI orders "grew meaningfully" in its fiscal first quarter. Cisco's November 12 report showed revenue up 24% to $18.5 billion and non-GAAP EPS of $1.40. In our view, the pullback after a strong report gives the valuation argument more weight.
Shares traded near $94.70 during Tuesday's session, up about 0.2%, giving Cisco a market capitalization near $372.83 billion. The 52-week range runs from $72.80 to $130.37, and the trailing P/E is about 25.2.
Consensus reads strong buy, with 11 of 14 tracked firms bullish and none bearish. The average target of $125.71 implies about 32.7% upside, and HSBC's target implies about 40.4%. Citi's Atif Malik kept a Buy rating on November 13 but cut his target to $120.00.
Risks: Non-GAAP gross margin slipped to 65.6% from 68.1% a year earlier as lower-margin AI hardware and memory costs weighed. Product order growth slowed to 21% from 35%. These remain factors to monitor.
Medtronic (MDT) β Piper Sandler Upgrades the Medical Device Giant
Piper Sandler analyst Matt O'Brien upgraded Medtronic to Overweight from Neutral and lifted his target to $120.00 from $85.00. He argued that the "aggregation of multiple growth drivers should result in top-line results ahead of the Street in the coming years." In our view, the large target increase signals a meaningful change in how the firm sees Medtronic's growth profile.
Shares traded near $103.11 during Tuesday's session, up about 0.2%, giving Medtronic a market capitalization near $131.90 billion. The stock sits near the top of its 52-week range of $73.31 to $106.33, with a trailing P/E of about 25.4.
Consensus reads strong buy, with 16 of 21 tracked firms bullish and none bearish. The average target of $106.19 implies only about 3.0% upside, so Piper Sandler's target, about 16.4% above the price, better reflects the new bull case. TD Cowen's Joshua Jennings reiterated a Buy rating with a $110.00 target on September 30.
Risks: Shares already trade near a 52-week high, and the average target leaves little cushion. Execution on newer growth products and broader medtech valuation swings remain factors to monitor.
BlackRock (BLK) β Mizuho Initiates the Asset Management Leader
Mizuho analyst Ryan Coyne started coverage of BlackRock at Outperform with a $1,450.00 target. He cited the company's "unmatched" scale, its number-one iShares index franchise, a "fast-scaling" private markets platform, and "peer-leading" organic growth and margins. In our view, BlackRock offers a steadier way to play capital markets activity than more volatile alternative managers.
Shares traded near $1,185.06 during Tuesday's session, down about 1.1%, giving BlackRock a market capitalization near $183.00 billion. The 52-week range spans $917.39 to $1,242.12, and the trailing P/E is about 27.0.
Consensus reads strong buy, with all 13 tracked firms bullish. The average target of $1,359.00 implies about 14.7% upside, while Mizuho's target implies about 22.4%. TD Cowen's Bill Katz upgraded the stock to Buy with a $1,405.00 target on October 20.
Risks: Asset-based fees move with market levels, so the broad selloff that began November 16 could weigh on results if it persists. Index fee pressure and private markets execution remain factors to monitor.
Walmart (WMT) β Stifel Resumes the Retail Giant at Buy
Stifel analyst Michael Montani resumed coverage of Walmart at Buy with a $145.00 target. Stifel explained that the target is "based on 44x our CY2027E EPS estimate of $3.30." Montani sees Walmart evolving from a scale-driven, low-price retailer into a higher-return omnichannel platform. In our view, the call arrives at a useful moment, two days before Walmart's fiscal third-quarter report on November 19.
Shares traded near $127.81 during Tuesday's session, down about 0.5%, giving Walmart a market capitalization near $1.02 trillion. The 52-week range runs from $99.68 to $135.16, and the trailing P/E is about 46.3.
Consensus reads strong buy, with 25 of 27 tracked firms bullish. The average target of $134.52 implies about 5.2% upside, and Stifel's target implies about 13.4%. Wells Fargo's Edward Kelly raised his target to $135.00 from $120.00 on November 13.
Risks: The premium multiple leaves little room for disappointment on November 19. Stifel itself flagged weaker consumer spending, more intense price competition, and elevated investor expectations, which remain factors to monitor.
Carvana (CVNA) β Stifel Initiates the Online Auto Retailer
Stifel also initiated coverage of Carvana at Buy with an $85.00 target, based on 24.5 times its 2027 adjusted EBITDA estimate of $4.10 billion. The firm projects about 1.05 million used-unit sales in 2027, in line with consensus, and 1.28 million in 2028, roughly 3% above the Street. In our view, the 2028 unit forecast is the key piece of the thesis.
Shares traded near $70.67 during Tuesday's session, roughly flat, giving Carvana a market capitalization near $77.51 billion. The 52-week range spans $54.46 to $97.38, and the trailing P/E is about 23.7.
Consensus reads strong buy, with 15 of 19 tracked firms bullish and none bearish. The average target of $85.20 implies about 20.6% upside, nearly matching Stifel's target, which implies about 20.3%. Barclays' John Babcock kept an Overweight rating with an $82.00 target on October 30.
Risks: Stifel listed gain-on-sale pricing, credit quality, used-car prices, and diesel costs as key risks. The stock also remains well below its 52-week high. These remain factors to monitor.
Found this helpful? Share it with others.